Final answer:
Her2/neu testing in breast cancer is used to identify patients who will benefit from targeted therapies such as Herceptin, a drug that improves survival rates in HER2-positive metastatic breast cancer when used alongside chemotherapy. Option A is correct.
Step-by-step explanation:
The role of Her2/neu testing in breast cancer is to determine targeted therapy options based on gene mutations. Specifically, HER2 is a cell-surface receptor that, when overexpressed due to gene duplication, contributes to the unregulated cell division seen in approximately 20-30 percent of human breast cancers.
Testing for HER2 overexpression is crucial because it can guide the use of targeted therapies like Herceptin (trastuzumab), which is a monoclonal antibody that targets the HER2 receptor. By binding to HER2, Herceptin helps control cellular signaling and can improve the overall survival rate of patients with HER2-positive metastatic breast cancer when used in combination with chemotherapy.